<VariationArchive VariationID="3254586" VariationName="NM_005654.6(NR2F1):c.53del (p.Gly18fs)" VariationType="Deletion" Accession="VCV003254586" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2024-07-23" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3413363" VariationID="3254586">
      <GeneList>
        <Gene Symbol="NR2F1" FullName="nuclear receptor subfamily 2 group F member 1" GeneID="7025" HGNC_ID="HGNC:7975" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>5q15</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="93583222" stop="93594611" display_start="93583222" display_stop="93594611" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="92919042" stop="92929787" display_start="92919042" display_stop="92929787" Strand="+" />
          </Location>
          <OMIM>132890</OMIM>
          <Haploinsufficiency last_evaluated="2022-08-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR2F1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-08-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR2F1">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="NR2F1-AS1" FullName="NR2F1 antisense RNA 1" GeneID="441094" HGNC_ID="HGNC:48622" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>5q15</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="93409356" stop="93585589" display_start="93409356" display_stop="93585589" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_005654.6(NR2F1):c.53del (p.Gly18fs)</Name>
      <CanonicalSPDI>NC_000005.10:93585071:GGGGG:GGGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q15</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="93585072" stop="93585072" display_start="93585072" display_stop="93585072" variantLength="1" positionVCF="93585071" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="92920778" stop="92920778" display_start="92920778" display_stop="92920778" variantLength="1" positionVCF="92920777" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>G18fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.93585076del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.93585076del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.92920782del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.92920782del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_034119.1" sequenceAccession="NG_034119" sequenceVersion="1" change="g.6740del">
            <Expression>NG_034119.1:g.6740del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005654.6" sequenceAccession="NM_005654" sequenceVersion="6" change="c.53del" MANESelect="true">
            <Expression>NM_005654.6:c.53del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005645.1" sequenceAccession="NP_005645" sequenceVersion="1" change="p.Gly18fs">
            <Expression>NP_005645.1:p.Gly18fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005654.6(NR2F1):c.53del (p.Gly18fs) AND Bosch-Boonstra-Schaaf optic atrophy syndrome" Accession="RCV004594769" Version="1">
        <ClassifiedConditionList TraitSetID="13444">
          <ClassifiedCondition DB="MedGen" ID="C3810363">Bosch-Boonstra-Schaaf optic atrophy syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-17" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-07-23" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26986877</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32275123</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13444" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18672" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Bosch-Boonstra-Schaaf optic atrophy syndrome</ElementValue>
                <XRef ID="MONDO:0014320" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BBSOAS</ElementValue>
                <XRef Type="MIM" ID="615722" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">NR2F1-Related Neurodevelopmental Disorder</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12903" />
                <XRef ID="12903" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36508512</ID>
                <ID Source="BookShelf">NBK587319</ID>
              </Citation>
              <XRef ID="401777" DB="Orphanet" />
              <XRef ID="C3810363" DB="MedGen" />
              <XRef ID="MONDO:0014320" DB="MONDO" />
              <XRef Type="MIM" ID="615722" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9873654" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_005654_5_NR2F1_c_53delG" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005086261" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26986877</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32275123</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.3, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Bosch-Boonstra-Schaaf optic atrophy syndrome (MIM#615722). Dominant negative has also been proposed as a likely mechanism for some missense variants found in the DNA-binding domain (PMID: 26986877). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (ClinVar, PMID: 32275123). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1102 - Strong phenotype match for this individual. (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR2F1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_21471</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005654.5:c.53delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615722" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9873654" TraitType="Disease" MappingType="XRef" MappingValue="615722" MappingRef="OMIM">
        <MedGen CUI="C3810363" Name="Bosch-Boonstra-Schaaf optic atrophy syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

